Stevenage Bioscience Catalyst is the UK's is co-located on the GlaxoSmithKline R&D facility in Stevenage; a leading location for companies to develop and commercialise cutting edge therapeutics.
The Campus is home to major organisations including GSK, the Cell & Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a cluster over 45 start-up companies which together have raised over £1.5 bn in funding since 2012.
Laboratory and office accommodation is provided within 5 separate buildings within the cluster and plans for future expansion are underway. The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, scientific equipment and scale up facilities that would otherwise be beyond the reach of small or medium-sized companies.